首页> 美国卫生研究院文献>Antimicrobial Agents and Chemotherapy >Development Validation and Routine Application of a High-Performance Liquid Chromatography Method Coupled with a Single Mass Detector for Quantification of Itraconazole Voriconazole and Posaconazole in Human Plasma
【2h】

Development Validation and Routine Application of a High-Performance Liquid Chromatography Method Coupled with a Single Mass Detector for Quantification of Itraconazole Voriconazole and Posaconazole in Human Plasma

机译:高效液相色谱法结合单个质谱检测器定量测定人血浆中伊曲康唑伏立康唑和泊沙康唑的开发验证和常规应用

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

We have developed and validated a high-performance liquid chromatography method coupled with a mass detector to quantify itraconazole, voriconazole, and posaconazole using quinoxaline as the internal standard. The method involves protein precipitation with acetonitrile. Mean accuracy (percent deviation from the true value) and precision (relative standard deviation percentage) were less than 15%. Mean recovery was more than 80% for all drugs quantified. The lower limit of quantification was 0.031 μg/ml for itraconazole and posaconazole and 0.039 μg/ml for voriconazole. The calibration range tested was from 0.031 to 8 μg/ml for itraconazole and posaconazole and from 0.039 to 10 μg/ml for voriconazole.
机译:我们已经开发并验证了一种高效液相色谱方法,并结合质量检测器,以喹喔啉为内标对伊曲康唑,伏立康唑和泊沙康唑进行定量。该方法包括用乙腈沉淀蛋白质。平均准确度(偏离真实值的百分比)和精确度(相对标准偏差百分比)小于15%。所有定量药物的平均回收率均超过80%。伊曲康唑和泊沙康唑的定量下限为0.031μg/ ml,伏立康唑的定量下限为0.039μg/ ml。伊曲康唑和泊沙康唑的校准范围为0.031至8μg/ ml,伏立康唑的校准范围为0.039至10μg/ ml。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号